MedTrace Logo

A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 2

NCT00670618 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 325

Last updated 2023-05-09

No results posted yet for this study

Summary

Influence of CPP-ACP paste and Elmex Medical Gel on the prevention of white spot lesions in orthodontic patients during fixed appliances.

Conditions

  • Early Caries Lesions

Interventions

DEVICE

CPP-ACP (GC Tooth Mousse)

Calcium and phosphate

DEVICE

CPP-ACP (GC MI Paste Plus)

Calcium, phosphate and fluoride

DEVICE

Fluoride (Elmex Medical Gel)

Fluoride

Sponsors & Collaborators

  • GC Europe

    collaborator INDUSTRY

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Guy De Pauw, MD, PhD · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-01
Primary Completion
2011-01-21
Completion
2011-04-26

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00670618 on ClinicalTrials.gov